Zobrazeno 1 - 10
of 702
pro vyhledávání: '"Urva S"'
Autor:
Knop FK; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Steno Diabetes Center Copenhagen, Herlev, Denmark., Urva S; Eli Lilly and Company, Indianapolis, Indiana, USA., Rettiganti M; Eli Lilly and Company, Indianapolis, Indiana, USA., Benson CT; Eli Lilly and Company, Indianapolis, Indiana, USA., Roell WC; Eli Lilly and Company, Indianapolis, Indiana, USA., Mather KJ; Eli Lilly and Company, Indianapolis, Indiana, USA., Haupt A; Eli Lilly and Company, Indianapolis, Indiana, USA., Pratt EJ; Eli Lilly and Company, Indianapolis, Indiana, USA.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Nov; Vol. 26 (11), pp. 5474-5478. Date of Electronic Publication: 2024 Aug 27.
Autor:
Mather KJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Mari A; Institute of Neuroscience, National Research Council, 2-35122 Padua, Italy., Heise T; Profil Institute for Metabolic Research, 41460 Neuss, Germany., DeVries JH; Profil Institute for Metabolic Research, 41460 Neuss, Germany., Hua M; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Urva S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Coskun T; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Haupt A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Heine RJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Pratt E; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Thomas MK; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Milicevic Z; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Nov 18; Vol. 109 (12), pp. 3046-3054.
Autor:
Martin JA; Eli Lilly and Company, Indianapolis, USA. Electronic address: martin_jennifer_a@lilly.com., Czeskis B; Eli Lilly and Company, Indianapolis, USA., Urva S; Eli Lilly and Company, Indianapolis, USA., Cassidy KC; Eli Lilly and Company, Indianapolis, USA.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Nov 01; Vol. 202, pp. 106895. Date of Electronic Publication: 2024 Sep 05.
Autor:
Sawant-Basak A; Clinical Pharmacology and Pharmacometrics, AstraZeneca, Waltham, MA, USA., Urva S; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Mukker JK; EMD Serono Research and Development Institute, Inc., affiliated with Merck KGaA, Darmstadt, Germany., Billerica, Massachusetts, USA., Haertter S; Clinical Pharmacology, Boehringer-Ingelheim Pharma, Ingelheim, Germany., Mariano D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Parasrampuria DA; Astellas Pharma Global Development, Inc, Chicago, IL, USA., Goteti K; EMD Serono Research and Development Institute, Inc., affiliated with Merck KGaA, Darmstadt, Germany., Billerica, Massachusetts, USA., Singh RSP; Clinical Pharmacology, Pfizer Inc., 1 Portland St., Cambridge, MA, USA., Chiney M; Gilead, Parsippany, NJ, USA., Liao MZ; Genentech, South San Francisco, CA, USA., Chang SS; Merck & Co., Inc., Upper Gwynedd, Pennsylvania, USA., Mehta R; Clinical Pharmacology Modeling and Simulation, GSK PLC, Durham, North Carolina, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 902-913. Date of Electronic Publication: 2024 Jul 07.
Autor:
Urva S; Eli Lilly and Company, Indianapolis, Indiana, USA., O'Farrell L; Eli Lilly and Company, Indianapolis, Indiana, USA., Du Y; Eli Lilly and Company, Indianapolis, Indiana, USA., Loh MT; Eli Lilly and Company, Indianapolis, Indiana, USA., Hemmingway A; Eli Lilly and Company, Indianapolis, Indiana, USA., Qu H; Eli Lilly and Company, Indianapolis, Indiana, USA., Alsina-Fernandez J; Eli Lilly and Company, Indianapolis, Indiana, USA., Haupt A; Eli Lilly and Company, Indianapolis, Indiana, USA., Milicevic Z; Eli Lilly and Company, Indianapolis, Indiana, USA., Coskun T; Eli Lilly and Company, Indianapolis, Indiana, USA.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Sep; Vol. 25 (9), pp. 2784-2788. Date of Electronic Publication: 2023 Jun 13.
Autor:
Feng P; Department of Pharmacy, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Chengdu, 610041, Sichuan, People's Republic of China.; Clinical Trial Center and National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Chengdu, 610041, Sichuan, People's Republic of China., Sheng X; Department of Pharmacy, Peking University First Hospital, No. 8 Xishiku St., Xicheng District, Beijing, 100034, People's Republic of China., Ji Y; Eli Lilly and Company, Shanghai, 19F, Centre T1, HKRI Taikoo, No. 288, Shimen No. 1 Road, Jingan District, Shanghai, 200041, People's Republic of China., Urva S; Eli Lilly and Company, Lilly Corporate Center, 893 Delaware St, Indianapolis, IN, 46285, USA., Wang F; Eli Lilly and Company, Shanghai, 19F, Centre T1, HKRI Taikoo, No. 288, Shimen No. 1 Road, Jingan District, Shanghai, 200041, People's Republic of China., Miller S; Eli Lilly and Company, Lilly Corporate Center, 893 Delaware St, Indianapolis, IN, 46285, USA., Qian C; Eli Lilly and Company, Shanghai, 19F, Centre T1, HKRI Taikoo, No. 288, Shimen No. 1 Road, Jingan District, Shanghai, 200041, People's Republic of China., An Z; Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Chengdu, 610041, Sichuan, People's Republic of China. 848948343@qq.com., Cui Y; Department of Pharmacy, Peking University First Hospital, No. 8 Xishiku St., Xicheng District, Beijing, 100034, People's Republic of China. cui.pharm@pkufh.com.; Institute of Clinical Pharmacology, Peking University First Hospital, Xueyuan Road 38, Haidian District, Beijing, 100191, People's Republic of China. cui.pharm@pkufh.com.
Publikováno v:
Advances in therapy [Adv Ther] 2023 Aug; Vol. 40 (8), pp. 3434-3445. Date of Electronic Publication: 2023 Jun 07.
Autor:
Urva S; Global PK/PD & Pharmacometrics, Eli Lilly and Company, Indianapolis, IN, USA., Levine JA; Diabetes and Obesity Global Medical Affairs, Eli Lilly and Company, Indianapolis, IN, USA., Schneck K; Pharmacometrics & QSP, Eli Lilly and Company, Indianapolis, IN, USA., Tang CC; Clinical Pharmacology Modeling and Simulation (CPMS), Parexel International, Singapore.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2024 Apr; Vol. 40 (4), pp. 567-574. Date of Electronic Publication: 2024 Mar 12.
Autor:
Schneck K; Global PK/PD & Pharmacometrics, Eli Lilly and Company, Indianapolis, Indiana, USA., Urva S; Global PK/PD & Pharmacometrics, Eli Lilly and Company, Indianapolis, Indiana, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Mar; Vol. 13 (3), pp. 494-503. Date of Electronic Publication: 2024 Feb 14.
Autor:
Mullins GR; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Hodsdon ME; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Li YG; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Anglin G; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Urva S; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Schneck K; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Bardos JN; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Martins RF; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Brown K; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Calderon B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Jan 18; Vol. 109 (2), pp. 361-369.
Autor:
Besse, B. *, Heist, R.S., Papadmitrakopoulou, V.A., Camidge, D.R., Beck, J.T., Schmid, P., Mulatero, C., Miller, N., Dimitrijevic, S., Urva, S., Pylvaenaeinen, I., Petrovic, K., Johnson, B.E.
Publikováno v:
In Annals of Oncology February 2014 25(2):505-511